Understanding Advanced Haemodynamic Variables: dP/dtmax, Ea, CCE and Beyond

Optimising haemodynamics requires moving beyond conventional parameters such as heart rate and blood pressure. While these remain useful, they can be misleading when used in isolation. In particular, arterial pressure should not be considered a surrogate for cardiac output or oxygen delivery, as compensatory mechanisms (e.g. increased systemic vascular resistance) may maintain pressure despite inadequate flow. 

Advanced haemodynamic variables provide deeper insight into the interaction between the heart and arterial system, supporting earlier detection of instability and more individualised management.

Key parameters include:

• dP/dtmax – a marker of contractility and signal quality
• Effective arterial elastance (Ea) – a measure of total arterial load
• Cardiac cycle efficiency (CCE) – an index of energetic efficiency
• Dynamic arterial elastance (EaDyn) – a functional marker of pressure response to flow changes

Together, these variables offer a more complete understanding of ventricular–arterial (V–A) coupling and cardiovascular performance.

1. dP/dtmax — A Dynamic Marker of Left Ventricular Contractility

dP/dtmax represents the maximum rate of arterial pressure rise during early systole, reflecting left ventricular contractility.

A steep upstroke correlates with strong systolic function, whereas a flattened slope suggests impaired contractility (1,10).

Contractility assessment

• Normal: ~1.0–1.5 mmHg/ms
• Reduced: <1.0 mmHg/ms → impaired contractility
• High: >1.5 mmHg/ms → hyperdynamic state

Signal quality check

A key additional insight is that very high dP/dt values (>1.7 mmHg/ms) indicate an underdamped arterial waveform, rather than true physiology.

This highlights a critical principle:

Advanced parameters are only reliable if the arterial waveform is accurate.

Clinicians should always:

• visually inspect the waveform
• compare invasive vs non-invasive blood pressure
• perform dynamic response testing (e.g. square wave test)

Failure to ensure signal quality may lead to misinterpretation and inappropriate treatment.

Clinical interpretation

• High dP/dtmax → strong contractility
• Low dP/dtmax → LV dysfunction, cardiogenic shock, or sedation‑related depression (1)

Peripheral arterial dP/dtmax has been shown to correlate with central LV systolic performance, and radial dP/dtmax predicts mortality in heart failure (10). dP/dt also changes rapidly in response to bleeding, fluid administration, beta‑blockade, and inotrope therapy, making it highly sensitive to shifts in cardiac function (3).

2. Effective Arterial Elastance (Ea) — Understanding Total Arterial Load

Ea is a global estimate of total arterial load, incorporating systemic resistance, arterial compliance, and the timing of reflected pressure waves. It is calculated as the ratio of end‑systolic pressure to stroke volume (7,8).

Physiological meaning

• High Ea → stiff arteries, higher afterload
• Low Ea → vasodilation or decreased arterial tone

Traditionally, afterload has been approximated by systemic vascular resistance (SVR).
However, SVR assumes a steady, simplified model of circulation.

Ea provides a global measure of arterial load, integrating both:

• steady components (resistance)
• pulsatile components (compliance, wave reflections)

This makes Ea more clinically informative than systemic vascular resistance alone.

Afterload is not just resistance, but the total opposition to ventricular ejection across the cardiac cycle.

Why this matters clinically:

• Two patients with identical SVR may have very different arterial stiffness
• Stiff arteries (high Ea) increase cardiac workload even if resistance appears normal

Clinical evidence

• Elevated Ea has been linked to worse outcomes in heart failure and septic shock, and reflects increased vascular stiffness (5,9).
• In the cardiac intensive care unit, higher elastance values correlate with increased in‑hospital and 1‑year mortality, emphasising its prognostic value (6).
• Ea also helps predict blood pressure response to fluids and vasopressors, guiding resuscitation and vasoactive titration (4).

3. Dynamic Arterial Elastance (EaDyn) — Predicting Pressure Response

EaDyn = PPV / SVV 

Unlike static Ea, EaDyn reflects how changes in stroke volume translate into changes in arterial pressure.

Interpretation

• High EaDyn: small changes in SV → large changes in MAP
  • ≥ 1.0 (High): Fluid administration is highly likely to increase blood pressure (provided the patient is preload-responsive)
• Low EaDyn: SV may increase without meaningful pressure rise 
  • < 1.0 (Low): Blood pressure will likely not increase with fluids alone. Vasopressors are generally required to raise blood pressure

Clinical applications

1. Vasopressor weaning

• High EaDyn before reducing vasopressors is associated with risk of hypotension

2. Fluid management

• Predicts whether fluid-induced increases in SV will translate into improved blood pressure

This is particularly valuable when PPV or SVV alone are inconclusive.

4. Cardiac Cycle Efficiency (CCE) — Tracking Energetic Performance

CCE quantifies the efficiency of the cardiovascular system by comparing the energy used during systole with the total energy expenditure over a cardiac cycle. It reflects the combined influence of LV contractility, arterial load, heart rate, preload, and afterload (2,7).

Interpreting CCE

• Positive CCE → effective V–A coupling and efficient energy transfer
• Negative CCE → high energy cost for maintaining stroke volume, often seen in heart failure, vasoplegia, or advanced shock

CCE responds quickly to changes in haemodynamics, making it valuable for tracking improvement or deterioration. It increases with effective fluid loading, improves with adequate afterload reduction, and falls when contractility worsens (2).

Practical uses

CCE is particularly useful when:

• a patient is deteriorating despite compensatory mechanisms
• titrating inotropes or vasopressors
• assessing impact of heart rate control

Supporting evidence

• A 2017 observational study showed that CCE, when combined with PPV and elastance-based markers, can predict fluid responsiveness within minutes, outperforming conventional static indicators (2).
• CCE has also been proposed as an early warning indicator for energetic failure and V–A mismatch, helping clinicians anticipate haemodynamic decline (7).

Integrating dP/dt, Ea, and CCE for Clinical Decision-Making

When interpreted together, these variables reveal haemodynamic patterns that single values cannot capture:

Clinical State	dP/dt	Ea	CCE	Interpretation
Healthy / efficient	High	Low–normal	Positive	Strong contractility, low afterload, efficient V–A coupling
Afterload mismatch	Low	High	Low	LV struggling against elevated afterload
Vasoplegia	Normal/Low	Low	Low	Poor tone reduces efficiency; fluids alone may not help
Fluid-responsive state	Improves	May fall	Improves	Haemodynamics benefit from volume expansion

These patterns help guide the choice between fluids, inotropes, vasopressors, or rate control, and support personalised cardiovascular management.

Conclusion

By integrating contractility (dP/dt), arterial load (Ea), pressure responsiveness (EaDyn), and energetic efficiency (CCE), clinicians can move beyond surface stability (e.g. “MAP ≥65 mmHg”) to understand:

• whether cardiac output is truly adequate
• whether interventions will work
• and whether the cardiovascular system is operating efficiently or at risk of failure

Critically:

• Normal arterial pressure does not guarantee adequate perfusion
• Fluid responsiveness does not guarantee a rise in blood pressure
• Stable patients can still be haemodynamically inefficient or unstable beneath compensation

Supported by strong clinical evidence, these parameters enhance bedside decision-making, enabling more precise, physiologically grounded haemodynamic management in perioperative, critical care, and cardiovascular settings.

References

1. Scolletta S, Bodson L, Donadello K, Taccone FS, Devigili A, Vincent JL, De Backer D. Assessment of left ventricular function by pulse wave analysis in critically ill patients. Intensive Care Med. 2013;39:1025–33.
2. Messina A, Romano SM, Bonicolini E, Colombo D, Cammarota G, Chiostri M, et al. Cardiac cycle efficiency and dicrotic pressure variations: new parameters for fluid therapy: A pilot observational study. Eur J Anaesthesiol. 2017;34:1–9.
3. Monge García MI, Jian Z, Settels JJ, Hatib F, Cecconi M, Pinsky MR. Dynamic arterial elastance as a predictor of arterial pressure response to volume loading. Front Physiol. 2020;11:284.
4. Ramirez P, Troianos C, Farag E, Tovar-Camargo O. Dynamic Arterial Elastance: Physiology, Data and Implementation. In: Perioperative Fluid Management. Springer; 2020. p. 143–52.
5. Brener MI, Burkhoff D, Sunagawa K. Effective arterial elastance in the pulmonary arterial circulation: derivation, assumptions, and clinical applications. Circ Heart Fail. 2020;13:e006591.
6. Padkins M, Kane GC, Thaden J, Tabi M, Barnett CF, Jentzer JC, et al. Pulmonary effective arterial elastance by echocardiography and mortality in the cardiac intensive care unit. Chest. 2024;166(4 Suppl):A398.
7. Chantler PD, Lakatta EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. J Appl Physiol. 2008;105(4):1342–51.
8. Nichols WW, O’Rourke MF. McDonald’s Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 4th ed. London: Edward Arnold; 1998:54–97, 243–283, 347–395.
9. Morelli A, Singer M, Ranieri VM, D’Egidio A, Mascia L, Orecchioni A, et al. Heart rate reduction with esmolol is associated with improved arterial elastance in septic shock: a prospective observational study. Intensive Care Med. 2016;42:1528–39.
10. Tartière JM, Tabet JY, Logeart D, Tartière-Kesri L, Beauvais F, Chavelas C, et al. Noninvasively determined radial dP/dt is a predictor of mortality in patients with heart failure. Am Heart J. 2008;155(4):758–63.